URN:NBN:SI:DOC-NMJIU4KG2023Janić, MiodragLunder, MojcaPučnik, Tinadocuments/doc/N/URN_NBN_SI_doc-NMJIU4KG_001.pdfdocuments/doc/N/URN_NBN_SI_doc-NMJIU4KG_001.txt11/1292articlestr. 468-47510.6016/ZdravVestn.34571318-0347183926531URN:NBN:SI:doc-NMJIU4KGslvSlovensko zdravniško društvoZdravniški vestnikBY-NCdapagliflozindiabetic ketoacidosisdiabetična ketoacidozaempagliflozinrisk factorsSGLT-2 inhibitorssprožilni dejavnikizaviralci SGLT-2Diabetična ketoacidozaredek, a resen zaplet zdravljenja z zaviralci SGLT-2 – pregled literature in prikaz serije primerovDiabetic ketoacidosisa rare but serious complication of treatment with SGLT-2 inhibitors – literature review and case series presentation